AEMD Earnings AETHLON MEDICAL INC
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–27 of 27
| Q1 2027 | 2026-06-30 | -4.02 | 2026-08-13 | 10-Q |
| Q4 2026 (derived) | 2026-03-31 | 20.32 | 2026-06-10 | 10-K |
| FY 2026 | 2026-03-31 | -53.05 | 2026-06-10 | 10-K |
| Q3 2026 | 2025-12-31 | -12.25 | 2026-02-12 | 10-Q |
| Q2 2026 | 2025-09-30 | -18.70 | 2025-11-12 | 10-Q |
| Q1 2026 | 2025-06-30 | -42.42 | 2025-08-13 | 10-Q |
| Q4 2025 (derived) | 2025-03-31 | -160.05 | 2025-06-26 | 10-K |
| FY 2025 | 2025-03-31 | -428.85 | 2025-06-26 | 10-K |
| Q3 2025 | 2024-12-31 | -50.25 | 2025-02-12 | 10-Q |
| Q2 2025 | 2024-09-30 | -80.55 | 2024-11-13 | 10-Q |
| Q1 2025 | 2024-06-30 | -138.00 | 2024-08-14 | 10-Q |
| Q4 2024 (derived) | 2024-03-31 | -1328.90 | 2024-06-27 | 10-K |
| FY 2024 | 2024-03-31 | -1943.50 | 2024-06-27 | 10-K |
| Q3 2024 | 2023-12-31 | -68.50 | 2024-02-14 | 10-Q |
| Q2 2024 | 2023-09-30 | -6.10 | 2023-11-14 | 10-Q |
| Q1 2023 | 2023-06-30 | -540.00 | 2023-08-10 | 10-Q |
| Q4 2023 (derived) | 2023-03-31 | -2264.25 | 2023-06-28 | 10-K |
| FY 2023 | 2023-03-31 | -2344.00 | 2023-06-28 | 10-K |
| Q3 2023 | 2022-12-31 | -62.00 | 2023-02-13 | 10-Q |
| Q2 2022 | 2022-09-30 | -9.20 | 2022-11-14 | 10-Q |
| Q1 2023 | 2022-06-30 | -8.55 | 2022-08-09 | 10-Q |
| Q4 2022 (derived) | 2022-03-31 | -1040.00 | — | — |
| FY 2022 | 2022-03-31 | -2840.00 | — | — |
| Q3 2022 | 2021-12-31 | -640.00 | — | — |
| Q2 2021 | 2021-09-30 | -520.00 | — | — |
| Q1 2022 | 2021-06-30 | -640.00 | — | — |
| Q3 2012 | 2012-12-31 | 0.00 | 2013-02-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.